Welcome to the webpage of the working group "Experimental Tumorpathology", Institute of Pathology at the University Hospital Erlangen at the Friedrich Alexander-University Erlangen-Nuremberg.
On March 1st, 2009, Dr. Regine Schneider-Stock, PhD, joined the Institute of Pathology at the University of Erlangen as a W2 Professor of Experimental Tumor Pathology. Our group has been cre-ated to reinforce further the focus of tumor biology at the University Hospital.
Dr. Regine Schneider-Stock, PhD, has a long-standing interest in understanding the molecular pathways of DNA- and cell damage caused by oxidative stress. We have an excellent expertise in molecular-genetic, epigenetic and biochemical analysis of apoptosis induction, and apoptosis resistance mechanisms in gastrointestinal tumors. Main focus is studying the role of Death-associated protein kinase (DAPK1) and transcription factor ATF2 in colorectal carcinogenesis. We have available the CAM model and various conditional ko mice for in vivo studies.